Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1. Axial contrast-enhanced T1-weighted subtraction MR images obtained 150 s after contrast injection in a 49-year-old premenopausal woman treated.

Published byPeter Walsh Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 1. Axial contrast-enhanced T1-weighted subtraction MR images obtained 150 s after contrast injection in a 49-year-old premenopausal woman treated."— Presentation transcript:

1 Fig. 1. Axial contrast-enhanced T1-weighted subtraction MR images obtained 150 s after contrast injection in a 49-year-old premenopausal woman treated for contralateral invasive ductal carcinoma. (a) Baseline image before treatment with tamoxifen obtained with 1.5T MRI system shows moderate BPE. (b) After 22 months from baseline study, follow-up 3.0T MR image during treatment with tamoxifen shows a decrease to minimal background parenchymal enhancement. Fig. 1. Axial contrast-enhanced T1-weighted subtraction MR images obtained 150 s after contrast injection in a 49-year-old premenopausal woman treated for contralateral invasive ductal carcinoma. (a) Baseline image before treatment with tamoxifen obtained with 1.5T MRI system shows moderate BPE. (b) After 22 months from baseline study, follow-up 3.0T MR image . . . Investig Magn Reson Imaging Jun;19(2):

Download ppt "Fig. 1. Axial contrast-enhanced T1-weighted subtraction MR images obtained 150 s after contrast injection in a 49-year-old premenopausal woman treated."

Similar presentations

Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.

Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.
Fig. 2. Computed tomography (CT) and magnetic resonance images of 34-year-old man with right nasal tumor diagnosed as cavernous hemangioma. A. Early-phase.

Fig. 2. Computed tomography (CT) and magnetic resonance images of 34-year-old man with right nasal tumor diagnosed as cavernous hemangioma. A. Early-phase.
Fig. 2. Imaging findings of the lesion on brain MRI

Fig. 2. Imaging findings of the lesion on brain MRI
Fig. 16. A 56-year-old woman, who was diagnosed ovarian cancer with metastatic cancer in left axilla, underwent breast MRI. (a, b) On axial T2 and T1 weighted.

Fig. 16. A 56-year-old woman, who was diagnosed ovarian cancer with metastatic cancer in left axilla, underwent breast MRI. (a, b) On axial T2 and T1 weighted.
Copyright © 2015 by the American Osteopathic Association.

Copyright © 2015 by the American Osteopathic Association.
Fig. 6. Neural compression: 59-year-old man with esophageal cancer visited for weakness of both lower extremities. Sagittal T1-weighted (TR/TE; 661/10)

Fig. 6. Neural compression: 59-year-old man with esophageal cancer visited for weakness of both lower extremities. Sagittal T1-weighted (TR/TE; 661/10)
Fig year-old woman with invasive lobular breast cancer. A

Fig year-old woman with invasive lobular breast cancer. A
Fig. 7. A 70-year-old woman with invasive lobular cancer involving right breast underwent breast MRI. (a, b) On axial breast MRI, segmental clumped nonmass.

Fig. 7. A 70-year-old woman with invasive lobular cancer involving right breast underwent breast MRI. (a, b) On axial breast MRI, segmental clumped nonmass.
Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old.

Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old.
Fig. 4. A 50-year-old woman with invasive ductal cancer involving left breast underwent breast MRI and PET-CT. (a, b) On axial breast MRI, irregular and.

Fig. 4. A 50-year-old woman with invasive ductal cancer involving left breast underwent breast MRI and PET-CT. (a, b) On axial breast MRI, irregular and.
Fig. 1. A 60-year-old woman with a palpable lump in right breast

Fig. 1. A 60-year-old woman with a palpable lump in right breast
Fig. 1. Luminal A type breast cancer of 37-year-old woman. A

Fig. 1. Luminal A type breast cancer of 37-year-old woman. A
Fig. 2. Triple negative type breast cancer of 37-year-old woman. A

Fig. 2. Triple negative type breast cancer of 37-year-old woman. A
Fig. 3. Follow-up MRI (4 weeks later) contrast-enhanced T1-weighted axial (a) and coronal (b) MRI, showed a marked decrease in the extent of the plaque-like.

Fig. 3. Follow-up MRI (4 weeks later) contrast-enhanced T1-weighted axial (a) and coronal (b) MRI, showed a marked decrease in the extent of the plaque-like.
Inflammatory Myofibroblastic Tumor of the Breast Coexisting with Breast Cancer: A Case Report Breast Care 2013;8:290-292 - DOI:10.1159/000354250 Fig.

Inflammatory Myofibroblastic Tumor of the Breast Coexisting with Breast Cancer: A Case Report Breast Care 2013;8: DOI: / Fig.
Fig. 1. Screening breast MR images of 31-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as negative finding.

Fig. 1. Screening breast MR images of 31-year-old woman with personal history of contralateral breast cancer.Breast MRI was reported as negative finding.
Fig year-old girl with juvenile rheumatoid arthritis

Fig year-old girl with juvenile rheumatoid arthritis
Fig. 1. (a) Axial portal phase contrast enhanced CT shows a cystic lesion with a thick wall in the portocaval space (arrows). An asterisk denotes the common.

Fig. 1. (a) Axial portal phase contrast enhanced CT shows a cystic lesion with a thick wall in the portocaval space (arrows). An asterisk denotes the common.
Fig. 2. Fatty tissue mimicking thyroid pyramidal lobe on ultrasonography in 49-year-old woman. Transverse (A) and longitudinal (B) gray-scale sonograms.

Fig. 2. Fatty tissue mimicking thyroid pyramidal lobe on ultrasonography in 49-year-old woman. Transverse (A) and longitudinal (B) gray-scale sonograms.
Fig. 1. T2* relaxation time mapping from 55-year-old woman with ductal carcinoma in situ. A. Sagittal contrast-enhanced T1-weighted image shows heterogeneous.

Fig. 1. T2* relaxation time mapping from 55-year-old woman with ductal carcinoma in situ. A. Sagittal contrast-enhanced T1-weighted image shows heterogeneous.

Similar presentations

Ads by Google